CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to REGN

Fixed Dose Combination (FDC) cemiplimab+fianlimab

Phase 2
Regeneron Pharmaceuticals, Inc. (REGN)

Phase 2

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q1 '27
REGNPhase 2

Fixed Dose Combination (FDC) cemiplimab+fianlimab Phase 2 Est. Readout

Fixed Dose Combination (FDC) cemiplimab+fianlimab
Q1 2027~QSTALE
CT.gov
00%
Nov '26
REGNPhase 2

cemiplimab Phase 2 Est. Readout

Fixed Dose Combination (FDC) cemiplimab+fianlimab
Nov 2026~
CT.gov
00%
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.